Document is current
Any future updates will be listed below
-
Authors
Giorgetti, Elisa
Obrecht, Michael
Ronco, Marie
Panesar, Moh
Lambert, Christian
Accart, Nathalie
Doelemeyer, Arno
Nash, Mark
Bidinosti, Michael
Beckmann, Nicolau
-
Funding
Funding for this research was provided by:
This work has been funded by Novartis Pharma AG in the context of the annual budget devoted by the company to pharmacological research.
- License Information
-
More Information
Article History
Received: 29 May 2019
Accepted: 24 August 2019
First Online: 18 September 2019
Competing Interests
: The authors are employed by Novartis Pharma AG, Basel, Switzerland and some of them have shares of the company. Novartis Pharma AG, is the funder of this study. There are no patents, products in development or marketed products to declare.
